APLN and heart failure: Apelin, which is a particularly potent inotropic agent, induces endothelium-mediated vasodilatation [51]; indicatively, chronic apelin administration to heart failure patients, which are characterized by low apelin levels, was observed to boost cardiac performance and output [52].